Receptor-interacting protein (RIP) kinase family
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Link
http://www.nature.com/articles/cmi201010.pdf
Reference85 articles.
1. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P . RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 2007; 14: 400–410.
2. Declercq W, Vanden Berghe T, Vandenabeele P . RIP kinases at the crossroads of cell death and survival. Cell 2009; 138: 229–232.
3. Meylan E, Tschopp J . The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 2005; 30: 151–159.
4. Korr D, Toschi L, Donner P, Pohlenz HD, Kreft B, Weiss B . LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain. Cell Signal 2006; 18: 910–920.
5. Stanger BZ, Leder P, Lee TH, Kim E, Seed B . RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995; 81: 513–523.
Cited by 151 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib;Biomedicines;2024-01-10
2. Design, synthesis and evaluation of novel thieno[2,3d]pyrimidine derivatives as potent and specific RIPK2 inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-01
3. Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer's disease;Biomedicine & Pharmacotherapy;2023-12
4. Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinases;European Journal of Medicinal Chemistry;2023-11
5. Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors;European Journal of Medicinal Chemistry;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3